Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Grossmann

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Leukemia|September 24, 2013
The role of different genetic subtypes of CEBPA mutated AMLA Fasan, C Haferlach, T Alpermann, et al.
Leukemia|July 18, 2013
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patientsS Weissmann, A Roller, S Jeromin, et al.
Leukemia|November 26, 2011
Landscape of TET2 mutations in acute myeloid leukemiaS Weissmann, T Alpermann, V Grossmann, et al.
Cytogenetic and Genome Research|April 21, 2012
Parental origin of de novo cytogenetically balanced reciprocal non-Robertsonian translocationsM Höckner, A Spreiz, A Frühmesser, et al.
Leukemia|May 8, 2013
Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristicsV Grossmann, U Bacher, C Haferlach, et al.
Leukemia|April 19, 2013
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, T Alpermann, M Wulfert, et al.
Clinical Genetics|June 30, 2010
Parental origin of apparently balanced de novo complex chromosomal rearrangements investigated by microdissection, whole genome amplification, and microsatellite-mediated haplotype analysisV Grossmann, M Höckner, H Karmous-Benailly, et al.
Leukemia|September 29, 2012
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcomeS Schnittger, C Eder, S Jeromin, et al.
Leukemia|May 12, 2016
The role of the RAS pathway in iAMP21-ALLS L Ryan, E Matheson, V Grossmann, et al.
Leukemia|November 14, 2013
Landscape of genetic lesions in 944 patients with myelodysplastic syndromesT Haferlach, Y Nagata, V Grossmann, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Leukemia|September 24, 2013
The role of different genetic subtypes of CEBPA mutated AMLA Fasan, C Haferlach, T Alpermann, et al.
Leukemia|July 18, 2013
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patientsS Weissmann, A Roller, S Jeromin, et al.
Leukemia|November 26, 2011
Landscape of TET2 mutations in acute myeloid leukemiaS Weissmann, T Alpermann, V Grossmann, et al.
Cytogenetic and Genome Research|April 21, 2012
Parental origin of de novo cytogenetically balanced reciprocal non-Robertsonian translocationsM Höckner, A Spreiz, A Frühmesser, et al.
Leukemia|May 8, 2013
Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristicsV Grossmann, U Bacher, C Haferlach, et al.
Leukemia|April 19, 2013
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, T Alpermann, M Wulfert, et al.
Clinical Genetics|June 30, 2010
Parental origin of apparently balanced de novo complex chromosomal rearrangements investigated by microdissection, whole genome amplification, and microsatellite-mediated haplotype analysisV Grossmann, M Höckner, H Karmous-Benailly, et al.
Leukemia|September 29, 2012
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcomeS Schnittger, C Eder, S Jeromin, et al.
Leukemia|May 12, 2016
The role of the RAS pathway in iAMP21-ALLS L Ryan, E Matheson, V Grossmann, et al.
Leukemia|November 14, 2013
Landscape of genetic lesions in 944 patients with myelodysplastic syndromesT Haferlach, Y Nagata, V Grossmann, et al.
Pageof 6